High dietary salt intake exerts damaging effects on renal and cardiovascular health and interacts with renin-angiotensin-aldosterone-system inhibitors in chronic kidney disease.
Does reduction of dietary salt intake improve renal and cardiovascular outcomes in patients with chronic kidney disease?
Reducing dietary salt intake may mitigate the burden of chronic kidney disease and improve the efficacy of RAAS inhibitors.
Although significant progress has been made in the treatment of chronic kidney disease (CKD), treatment is not yet satisfactory, particularly when it is started in the late stages of the disease. Novel modes of intervention to mitigate the burden of disease are required. The reduction of dietary salt intake (which is high in the industrialized world) is one such option. Better understanding of the deleterious effects of salt on renal and cardiovascular health is necessary to raise awareness of the importance of reduction of the salt content in food products. Therefore, we (i) review pathways through which high salt intake exerts damaging effects, (ii) provide an assessment of recent observational studies linking dietary salt intake to the progression of renal and cardiovascular disease and (iii) discuss the interaction between salt intake and rennin-angiotensin-aldosterone-system inhibitors, i.e. the first choice antihypertensive agents for the treatment of CKD.
Heerspink et al. (Fri,) conducted a review in Chronic kidney disease (CKD). Dietary salt intake was evaluated. High dietary salt intake exerts damaging effects on renal and cardiovascular health and interacts with renin-angiotensin-aldosterone-system inhibitors in chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: